[Further clinical observations on the treatment of noncirrhotic alcoholic liver disease].
After an experiment comparative clinical study, the authors could point out that biohumoral, semeiological and histopathological alterations in alcoholic hepatopaties, can retrograde only by the suspending the pathogenic alcoholic noxa, and that the improvement can be accelerated by a contemporary administration of a. cycloxilic, thiazolidine carboxylic of argynin, EPL: all antisteatosis substances helping the oxidation of alcohol and fat acids, potentiating the rigeneration of the hepatocyte and resolving the hepatosecretory function alterated.
D000328:Adult; D000368:Aged; D001120:Arginine / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008108:Liver Diseases, Alcoholic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*; D053778:Thiazolidines
D003509:Cyclohexanecarboxylic Acids; D010713:Phosphatidylcholines; D013844:Thiazoles; D053778:Thiazolidines; C018873:cicloxilic acid; C020213:arginine thiazolidinecarboxylate; D001120:Arginine
Ulteriori osservazioni cliniche sul trattamento dell'epatopatia alcolica non cirrogena.